ARRZX
Price
$13.17
Change
+$0.12 (+0.92%)
Updated
Aug 21 closing price
Net Assets
45.69M
VEMPX
Price
$459.71
Change
+$3.92 (+0.86%)
Updated
Aug 21 closing price
Net Assets
93.63B
Interact to see
Advertisement

ARRZX vs VEMPX

ARRZX vs VEMPX Comparison Chart in %
View a ticker or compare two or three
VS
ARRZX vs. VEMPX commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRZX is a Hold and VEMPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMPX has more cash in the bank: 93.6B vs. ARRZX (45.7M). VEMPX (1.05) and ARRZX (1.02) have matching dividends . ARRZX was incepted earlier than VEMPX: ARRZX (9 years) vs VEMPX (16 years). ARRZX (0.97) is less costly to investors than VEMPX (0.04). ARRZX is a more actively managed with annual turnover of: 92.00 vs. VEMPX (12.00). ARRZX has a lower initial minimum investment than VEMPX: ARRZX (5000000) vs VEMPX (100000000). VEMPX annual gain was more profitable for investors over the last year : 23.90 vs. ARRZX (-7.10). VEMPX return over 5 years is better than : 36.17 vs. ARRZX (-9.61).
ARRZXVEMPXARRZX / VEMPX
Total Expense Ratio0.780.042,229%
Annual Report Gross Expense Ratio0.970.042,771%
Fund Existence9 years16 years-
Gain YTD0.76517.6344%
Front LoadN/AN/A-
Min. Initial Investment50000001000000005%
Min. Initial Investment IRAN/AN/A-
Net Assets45.7M93.6B0%
Annual Yield % from dividends1.021.0598%
Returns for 1 year-7.1023.90-30%
Returns for 3 years9.6569.8414%
Returns for 5 years-9.6136.17-27%
Returns for 10 yearsN/A178.78-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NECOX23.990.28
+1.18%
Natixis Oakmark C
HAORX20.130.22
+1.10%
Harbor International Core Retirement
JFAMX52.140.53
+1.03%
JPMorgan Emerging Markets Equity A
JABYX10.540.06
+0.57%
JHancock Global Environmental Opps C
IJSIX14.91N/A
N/A
VY® JPMorgan Small Cap Core Equity I